Journal List > Tuberc Respir Dis > v.75(5) > 1001875

Koh, Chang, Jeong, Jeon, Kim, Lee, Ki, and Kwon: Increasing Recovery of Nontuberculous Mycobacteria from Respiratory Specimens over a 10-Year Period in a Tertiary Referral Hospital in South Korea

Abstract

Background

The number of patients with pulmonary disease caused by nontuberculous mycobacteria (NTM) has been increasing worldwide. The aim of this study was to evaluate long-term trends in the NTM recovery rate from respiratory specimens over a 10-year period in a tertiary referral hospital in South Korea.

Methods

We retrospectively reviewed the records of mycobacterial cultures of respiratory specimens at Samsung Medical Center from January 2001 to December 2011.

Results

During the study period, 32,841 respiratory specimens from 10,563 patients were found to be culture-positive for mycobacteria. These included 12,619 (38%) Mycobacterium tuberculosis and 20,222 (62%) NTM isolates. The proportion of NTM among all positive mycobacterial cultures increased from 43% (548/1,283) in 2001 to 70% (3,341/4,800) in 2011 (p<0.001, test for trend). The recovery rate of NTM isolates from acid-fast bacilli smear-positive specimens increased from 9% (38/417) in 2001 to 64% (1,284/1,997) in 2011 (p<0.001, test for trend). The proportion of positive liquid cultures was higher for NTM than for M. tuberculosis (p<0.001). The most frequently isolated NTM were Mycobacterium avium-intracellulare complex (53%) and Mycobacterium abscessus-massiliense complex (25%).

Conclusion

The recovery rate of NTM from respiratory specimens in South Korea has increased steadily.

Introduction

Mycobacteria other than Mycobacterium tuberculosis complex and Mycobacterium leprae are referred to as nontuberculous mycobacteria (NTM)1,2. The incidence of lung disease caused by NTM in human immunodeficiency virus-negative patients has been increasing worldwide3-8. In addition, distribution of the NTM variants is not uniform, and there is a marked geographic variability in both the prevalence of NTM lung disease and the mycobacterial species responsible9,10.
In South Korea, an intermediate tuberculosis (TB)-burden country, TB remains a serious public health problem. In countries with a high TB prevalence, patients with acid-fast bacilli (AFB)-positive sputum based on direct microscopic examination are considered positive for pulmonary TB and are treated empirically with anti-tuberculous drugs. This results in incorrect diagnoses or the unnecessary treatment of many patients with NTM11-13. NTM isolation in South Korea has increased, and differentiating between pulmonary TB and NTM lung disease is an important issue in clinical practice12,14,15.
The aim of this study was to evaluate long-term trends in the recovery rate of NTM from respiratory specimens over 10-year period in a tertiary referral hospital in South Korea.

Materials and Methods

1. Study subjects

We retrospectively reviewed records from the Mycobacteriology Laboratory of Samsung Medical Center during the 11-year period from January 2001 to December 2011. Samsung Medical Center is a tertiary referral hospital in Seoul, South Korea, with 1,299 beds until 2007. In January 2008, 652 beds were added, giving a total of 1,951 beds. All identified NTM isolates were considered significant, with the exception of Mycobacterium gordonae, a well-known environmental contaminant16-18. Respiratory isolates from sputum, tracheal aspirate or bronchial washing specimens were included in this study and NTM isolates from non-respiratory specimens were excluded. The Institutional Review Board at Samsung Medical Center approved the study protocol. Informed consent was waived because of the retrospective nature of the study.

2. Specimen processing

Clinical specimens were stained using the Ziehl-Neelsen method according to the guidelines provided by the American Thoracic Society19. A positive smear was defined as containing>1 AFB per 100 high-power fields. Respiratory specimens were decontaminated using the 2% N-acetyl-L-cysteine-sodium hydroxide (NALC-NaOH) method. Solid media for mycobacterial culture were used. The processed specimens were plated onto 3% Ogawa solid media (Shinyang, Seoul, Korea) between 2001 and 200820. A liquid culture system, a mycobacterial growth indicator tube (MGIT 960 system; Becton Dickinson, Sparks, MD, USA), was introduced from January 2009, and both solid and liquid media were incubated for 6 weeks between 2009 and 201121. All positive cultures were subjected to AFB staining to confirm the presence of AFB and exclude contamination. In addition, positive liquid cultures were confirmed based on the presence of cord formation and MPT64 antigen tests (SD BIOLINE TB Ag MPT64 Rapid; Standard Diagnostics, Yongin, Korea). If these tests were negative, conventional polymerase chain reaction (PCR) using the MTB-ID V3 kit (M&D, Wonju, Korea) was performed to differentiate between M. tuberculosis and NTM. Positive cultures in solid media were also confirmed by conventional PCR. To identify NTM species, A PCR-restriction fragment length polymorphism method based on the rpoB gene was used to identify the NTM to the species level18.

3. Statistical analysis

Data are expressed as numbers and percentage. Categorical variables were analyzed using Pearson's χ2 test or Fisher's exact test. A p-value of <0.05 was considered to indicate statistical significance. All statistical tests were performed using PASW version 18.0 (SPSS Inc., Chicago, IL, USA).

Results

1. Annual numbers of mycobacterial isolates and patients

From 2001 to 2011, the number of samples requested for mycobacterial culture increased steadily from 10,931 in 2001 to 22,966 in 2011. During this period, 32,841 respiratory specimens from 10,563 patients were mycobacteria-positive. These included 12,619 (38%) M. tuberculosis and 20,222 (62%) NTM isolates.
The changes in the recovery rates of M. tuberculosis and NTM among the requested specimens differed during the study period. The annual rate of NTM isolation from requested specimens increased from 5% in 2001 to 15% in 2011 (p<0.0001, test for trend), while M. tuberculosis isolation remained stable, being 6% in both 2001 and 2011 (p=0.710, test for trend) (Figure 1). The annual number of NTM isolates increased rapidly from 548 in 2001 to 3,341 in 2011, while the annual number of M. tuberculosis isolates was 735 in 2001 which increased steadily to 1,459 in 2011 (Table 1).

2. Proportion of NTM among mycobacterial isolates

The proportion of M. tuberculosis and NTM among all positive mycobacterial cultures changed significantly. The proportion of NTM among all positive mycobacterial cultures increased from 43% (548/1,283) in 2001 to 70% (3,341/4,800) in 2011 (p<0.001, test for trend) (Figure 2).

3. Proportion of NTM among AFB smear-positive specimens

Of the 12,876 AFB smear-positive respiratory specimens, M. tuberculosis was recovered from 6,611 (51%) and NTM from 6,265 (49%) during the study period. The proportion of NTM isolates increased from 9% (38/417) in 2001 to 64% (1,284/1,997) in 2011 (p<0.001, test for trend) (Figure 3).

4. Influence of liquid culture on NTM recovery

To evaluate the influence of the liquid culture system on the rapid increase in NTM isolation, we analyzed the recovery rate of mycobacteria from liquid and solid media from 2009 to 2011. During this 3-year period, both solid and liquid media were used simultaneously to isolate mycobacteria from 69,219 respiratory specimens. Of these, 14,685 (21%) specimens were positive for M. tuberculosis or NTM. Among all positive cultures, 27% of M. tuberculosis and 38% of NTM were recovered in only liquid media (p<0.001). In liquid media, the proportion of AFB smear-negative specimens positive for NTM (51%) was higher than for M. tuberculosis (38%) (p<0.001) (Table 2).

5. Prevalent NTM species from respiratory specimens

During the study period, the most frequently isolated NTM organisms were Mycobacterium avium-intracellulare complex (53%), Mycobacterium abscessus-massiliense complex (25%), Mycobacterium fortuitum (6%), and Mycobacterium kansasii (1%). The proportion of M. avium-intracellulare complex increased steadily (Figure 4).

Discussion

The recovery rate of NTM among requested specimens and the annual number of NTM isolates increased steadily over a 10-year period at our institution, particularly after 2009 when the liquid culture system was introduced, while the number of M. tuberculosis isolates remained. NTM were isolated more frequently than M. tuberculosis in the latter part of the study period. Moreover, NTM was isolated from more than 50% of AFB smear-positive respiratory specimens in recent years, which was traditionally considered diagnostic criterion of pulmonary TB in countries with a high TB burden.
The incidence and prevalence of NTM lung disease has been increasing worldwide, including in South Korea14,15,18,22. There are several explanations for the increased recovery of NTM. First, improved laboratory techniques have likely enhanced recovery of mycobacteria. For example, the introduction of liquid culture methods allowed for sensitive detection of both M. tuberculosis and NTM. The increased recovery rate was more prominent for NTM than M. tuberculosis, especially in AFB smear-negative respiratory specimens, when liquid culture methods were combined with solid medium for mycobacterial culture, as reported previously23. However, the increase in NTM isolates and patients with NTM lung disease could not be fully explained by the introduction of liquid culture methods at our institution. The annual number of NTM isolates and the number of patients with NTM isolates were more than those of M. tuberculosis from 2005 or 2006 when the liquid culture system had not been in use at our institution. Thus, there could be a true increase in the number of NTM isolates.
Both the environmental sources and host factors could be reasons for rapid increase of recovery of NTM in Korea. It is generally accepted that environmental sources, especially municipal water systems, are the reservoir for most human infections caused by NTM. Aerosolized water exposure within modern populations (e.g., showers, hot tubs, etc.) could be an important reservoir for NTM lung disease9. Given that some host factors such as old age and chronic obstructive pulmonary disease is risk factors of NTM lung disease24,25, the increase of the number of aging population and the prevalence of chronic obstructive pulmonary disease could also contribute to the increase of NTM isolates in Korea.
NTM has been isolated from more than 50% of AFB smear-positive respiratory specimens in recent years. Although the definitive diagnosis of pulmonary TB normally requires isolation of M. tuberculosis from respiratory specimens, TB detection is based primarily on the microscopic examination of sputum for AFB19. At our institution, the recovery rate of NTM from AFB smear-positive sputum specimens between 1998 and 2001 was 9%12. Therefore, early differentiation between pulmonary TB and NTM lung disease in patients with AFB smear-positive specimens is very important26,27. There is considerable overlap in the clinical and radiographic characteristics of pulmonary TB and NTM lung disease26. Nucleic acid amplification tests for laboratory diagnosis of pulmonary TB could be used to exclude TB in patients with AFB smear-positive samples28.
There is marked geographic variability in the distribution of the NTM species9,10. In many countries, M. avium-intracellulare complex is the most commonly isolated NTM organism, followed by M. kansasii1,6. In this study, M. avium-intracellulare complex and M. abscessus-massiliense complex accounted for the majority of isolated NTM species, while M. kansasii was relatively uncommon. This is in agreement with previous reports from South Korea15,18,22,29.
Our study has several limitations. First, it was a retrospective survey at a single tertiary referral hospital. Thus, our data could be biased by the demographic and clinical characteristics of the patients visiting our hospital. Second, the clinical significance of the isolated NTM was not evaluated, because we could not obtain the clinical and radiological data of the patients with NTM. Third, this study analyzed the number of culture-positive mycobacterial isolates rather than the number of patients with positive mycobacterial culture. Therefore, our data does not permit us to estimate the true change of disease prevalence during the study period.
In conclusion, the recovery rate of NTM from respiratory specimens at our institution has been increasing steadily over a 10-year period, particularly after 2009 when the liquid culture system was introduced. NTM are now isolated from more than 50% of AFB smear-positive respiratory specimens. Therefore, early differentiation between pulmonary TB and NTM lung disease in patients with AFB smear-positive specimens in South Korea is critical.

Figures and Tables

Figure 1
Changes in the rate of recovery of mycobacteria from respiratory specimens. The annual percentage of nontuberculous mycobacteria (NTM) isolated (filled circles) from requested specimens increased, while that of Mycobacterium tuberculosis (open circles) remained stable.
trd-75-199-g001
Figure 2
Changes in the proportions of Mycobacterium tuberculosis and nontuberculous mycobacteria (NTM) of all positive mycobacterial cultures during the study period. The proportion of NTM increased significantly.
trd-75-199-g002
Figure 3
Changes in the proportion of Mycobacterium tuberculosis and nontuberculous mycobacteria (NTM) of acid-fast bacilli smear-positive respiratory specimens. The proportion of NTM increased rapidly during the study period. AFB: acid-fast bacilli.
trd-75-199-g003
Figure 4
Prevalence of nontuberculous mycobacteria (NTM) species in respiratory specimens. Mycobacterium avium-intracellulare complex (MAC) and Mycobacterium abscessus-massiliense complex accounted for the majority of the isolated NTM species.
trd-75-199-g004
Table 1
The number of mycobacterial isolates of Mycobacterium tuberculosis and NTM
trd-75-199-i001

NTM: nontuberculous mycobacteria.

Table 2
Mycobacteria recovery rate after introduction of the liquid culture system (2009-2011)
trd-75-199-i002

NTM: nontuberculous mycobacteria; AFB: acid-fast bacilli.

Acknowledgements

This work was supported by the Mid-career Researcher Program through a National Research Foundation grant funded by the Ministry of Education, Science and Technology (2011-0015546) and the Samsung Biomedical Research Institute grant (#SBRI C-B1-101).

References

1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175:367–416.
2. Daley CL, Griffith DE. Pulmonary non-tuberculous mycobacterial infections. Int J Tuberc Lung Dis. 2010; 14:665–671.
3. Andrejak C, Thomsen VO, Johansen IS, Riis A, Benfield TL, Duhaut P, et al. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med. 2010; 181:514–521.
4. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010; 182:970–976.
5. Thomson RM. NTM working group at Queensland TB Control Centre and Queensland Mycobacterial Reference Laboratory. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis. 2010; 16:1576–1583.
6. Simons S, van Ingen J, Hsueh PR, Van Hung N, Dekhuijzen PN, Boeree MJ, et al. Nontuberculous mycobacteria in respiratory tract infections, eastern Asia. Emerg Infect Dis. 2011; 17:343–349.
7. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012; 185:881–886.
8. Al-Houqani M, Jamieson F, Mehta M, Chedore P, May K, Marras TK. Aging, COPD, and other risk factors do not explain the increased prevalence of pulmonary Mycobacterium avium complex in Ontario. Chest. 2012; 141:190–197.
9. Kendall BA, Winthrop KL. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013; 34:87–94.
10. Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: A NTM-NET collaborative study. Eur Respir J. 2013; 04. 08. [Epub]. http://dx.doi.org/10.1183/09031936.00149212.
11. van Crevel R, de Lange WC, Vanderpuye NA, van Soolingen D, Hoogkamp-Korstanje JA, van Deuren KM, et al. The impact of nontuberculous mycobacteria on management of presumed pulmonary tuberculosis. Infection. 2001; 29:59–63.
12. Jeon K, Koh WJ, Kwon OJ, Suh GY, Chung MP, Kim H, et al. Recovery rate of NTM from AFB smear-positive sputum specimens at a medical centre in South Korea. Int J Tuberc Lung Dis. 2005; 9:1046–1051.
13. Maiga M, Siddiqui S, Diallo S, Diarra B, Traore B, Shea YR, et al. Failure to recognize nontuberculous mycobacteria leads to misdiagnosis of chronic pulmonary tuberculosis. PLoS One. 2012; 7:e36902.
14. Park YS, Lee CH, Lee SM, Yang SC, Yoo CG, Kim YW, et al. Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea. Int J Tuberc Lung Dis. 2010; 14:1069–1071.
15. Yoo JW, Jo KW, Kim MN, Lee SD, Kim WS, Kim DS, et al. Increasing trend of isolation of non-tuberculous mycobacteria in a tertiary university hospital in South Korea. Tuberc Respir Dis. 2012; 72:409–415.
16. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979; 119:107–159.
17. Choudhri S, Manfreda J, Wolfe J, Parker S, Long R. Clinical significance of nontuberculous mycobacteria isolates in a Canadian tertiary care center. Clin Infect Dis. 1995; 21:128–133.
18. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest. 2006; 129:341–348.
19. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 2000; 161(4 Pt 1):1376–1395.
20. Kim JH, Kim YJ, Ki CS, Kim JY, Lee NY. Evaluation of Cobas TaqMan MTB PCR for detection of Mycobacterium tuberculosis. J Clin Microbiol. 2011; 49:173–176.
21. Koh WJ, Ko Y, Kim CK, Park KS, Lee NY. Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system. Ann Lab Med. 2012; 32:264–269.
22. Lee SK, Lee EJ, Kim SK, Chang J, Jeong SH, Kang YA. Changing epidemiology of nontuberculous mycobacterial lung disease in South Korea. Scand J Infect Dis. 2012; 44:733–738.
23. Chihota VN, Grant AD, Fielding K, Ndibongo B, van Zyl A, Muirhead D, et al. Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting. Int J Tuberc Lung Dis. 2010; 14:1024–1031.
24. Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med. 2008; 178:1066–1074.
25. Andrejak C, Nielsen R, Thomsen VO, Duhaut P, Sorensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax. 2013; 68:256–262.
26. Koh WJ, Yu CM, Suh GY, Chung MP, Kim H, Kwon OJ, et al. Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. Int J Tuberc Lung Dis. 2006; 10:1001–1007.
27. Grubek-Jaworska H, Walkiewicz R, Safianowska A, Nowacka-Mazurek M, Krenke R, Przybylowski T, et al. Nontuberculous mycobacterial infections among patients suspected of pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis. 2009; 28:739–744.
28. Greco S, Girardi E, Navarra A, Saltini C. Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax. 2006; 61:783–790.
29. Ryoo SW, Shin S, Shim MS, Park YS, Lew WJ, Park SN, et al. Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans. J Clin Lab Anal. 2008; 22:415–420.
TOOLS
ORCID iDs

Byeong-Ho Jeong
https://orcid.org/http://orcid.org/0000-0002-3124-1718

Similar articles